BR112012008483A2 - combunações de um inibidor de pi3k e um inibidor de mex - Google Patents
combunações de um inibidor de pi3k e um inibidor de mexInfo
- Publication number
- BR112012008483A2 BR112012008483A2 BR112012008483A BR112012008483A BR112012008483A2 BR 112012008483 A2 BR112012008483 A2 BR 112012008483A2 BR 112012008483 A BR112012008483 A BR 112012008483A BR 112012008483 A BR112012008483 A BR 112012008483A BR 112012008483 A2 BR112012008483 A2 BR 112012008483A2
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitor
- mex
- combinations
- pi3k
- pi3k inhibitor
- Prior art date
Links
- 239000012828 PI3K inhibitor Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229940043441 phosphoinositide 3-kinase inhibitor Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25085209P | 2009-10-12 | 2009-10-12 | |
PCT/EP2010/065149 WO2011054620A1 (en) | 2009-10-12 | 2010-10-11 | Combinations of a pi3k inhibitor and a mek inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012008483A2 true BR112012008483A2 (pt) | 2019-09-24 |
Family
ID=43072663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012008483A BR112012008483A2 (pt) | 2009-10-12 | 2010-10-11 | combunações de um inibidor de pi3k e um inibidor de mex |
Country Status (24)
Country | Link |
---|---|
US (1) | US20110086837A1 (pt) |
EP (1) | EP2488178B1 (pt) |
JP (2) | JP2013507415A (pt) |
KR (1) | KR101489045B1 (pt) |
CN (1) | CN102740851B (pt) |
AR (1) | AR078588A1 (pt) |
AU (1) | AU2010314287A1 (pt) |
BR (1) | BR112012008483A2 (pt) |
CA (1) | CA2776944A1 (pt) |
CL (1) | CL2012000913A1 (pt) |
CO (1) | CO6531463A2 (pt) |
CR (1) | CR20120173A (pt) |
EC (1) | ECSP12011865A (pt) |
ES (1) | ES2609767T3 (pt) |
HK (1) | HK1175125A1 (pt) |
IL (1) | IL219105A0 (pt) |
MA (1) | MA33974B1 (pt) |
MX (1) | MX345155B (pt) |
NZ (1) | NZ599939A (pt) |
PE (1) | PE20121816A1 (pt) |
RU (1) | RU2563193C2 (pt) |
TW (1) | TWI428336B (pt) |
WO (1) | WO2011054620A1 (pt) |
ZA (1) | ZA201202618B (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011000440A (es) | 2008-07-11 | 2011-02-24 | Novartis Ag | Combinacion de (a) un inhibidor de fosfoinositido 3-cinasa y (b) un modulador de la ruta de ras/raf/mek. |
SG196815A1 (en) | 2009-01-08 | 2014-02-13 | Curis Inc | Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
CA2786002C (en) | 2009-12-31 | 2018-10-02 | Joaquin Pastor Fernandez | Tricyclic compounds for use as kinase inhibitors |
WO2012098387A1 (en) | 2011-01-18 | 2012-07-26 | Centro Nacional De Investigaciones Oncológicas (Cnio) | 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors |
AU2012236367B2 (en) | 2011-04-01 | 2014-10-09 | Curis, Inc. | Phosphoinositide 3-kinase inhibitor with a zinc binding moiety |
ES2708669T3 (es) | 2011-08-01 | 2019-04-10 | Hoffmann La Roche | Procedimientos de tratamiento del cáncer usando antagonistas de unión al eje de PD-1 e inhibidores de MEK |
US9675595B2 (en) | 2011-08-31 | 2017-06-13 | Novartis Ag | Synergistic combinations of PI3K- and MEK-inhibitors |
CA2849331A1 (en) | 2011-10-13 | 2013-04-18 | Genentech, Inc. | Treatment of pharmacological-induced hypochlorhydria |
TW201325613A (zh) * | 2011-10-28 | 2013-07-01 | Genentech Inc | 治療黑色素瘤之治療組合及方法 |
WO2013082511A1 (en) | 2011-12-02 | 2013-06-06 | Genentech, Inc. | Methods for overcoming tumor resistance to vegf antagonists |
SG11201406199TA (en) * | 2012-04-06 | 2014-10-30 | Sanofi Sa | Methods for treating cancer using pi3k inhibitor and mek inhibitor |
JP6093757B2 (ja) * | 2012-04-19 | 2017-03-08 | 国立大学法人九州大学 | 医薬組成物 |
CN109939236A (zh) | 2012-06-08 | 2019-06-28 | 豪夫迈·罗氏有限公司 | 用于治疗癌症的磷酸肌醇3激酶抑制剂化合物和化疗剂的突变选择性及组合 |
RU2015106673A (ru) | 2012-08-02 | 2016-09-20 | Дженентек, Инк. | Антитела к рецептору эндотелина типа в (etbr) и иммуноконъюгаты |
KR20150032886A (ko) | 2012-08-02 | 2015-03-30 | 제넨테크, 인크. | 항-etbr 항체 및 면역접합체 |
CN110251512A (zh) * | 2012-08-17 | 2019-09-20 | 霍夫曼-拉罗奇有限公司 | 包括给药cobimetinib和威罗菲尼的黑色素瘤的组合疗法 |
MX2015010854A (es) * | 2013-03-14 | 2016-07-20 | Genentech Inc | Combinaciones de un compuesto inhibidor de mek con un compuesto inhibidor de her3/egfr y metodos de uso. |
US9532987B2 (en) | 2013-09-05 | 2017-01-03 | Genentech, Inc. | Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases |
FI3698790T3 (fi) * | 2014-02-07 | 2023-06-06 | Verastem Inc | Menetelmiä epänormaalin solukasvun hoitamiseksi |
EP3169361B1 (en) | 2014-07-15 | 2019-06-19 | F.Hoffmann-La Roche Ag | Compositions for treating cancer using pd-1 axis binding antagonists and mek inhibitors |
JP6692798B2 (ja) * | 2014-09-11 | 2020-05-13 | ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・カリフオルニア | mTORC1阻害剤 |
SG11202102343QA (en) | 2018-09-11 | 2021-04-29 | Curis Inc | Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety |
CN110420330B (zh) * | 2019-07-19 | 2020-05-29 | 南京医科大学 | 一种pi3k与mth1靶向药组合物的制药用途 |
WO2021047783A1 (en) | 2019-09-13 | 2021-03-18 | The Institute Of Cancer Research: Royal Cancer Hospital | Vs-6063 in combination with ch5126766 for the treatment of cancer |
US11873296B2 (en) | 2022-06-07 | 2024-01-16 | Verastem, Inc. | Solid forms of a dual RAF/MEK inhibitor |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1470356A1 (de) * | 1964-01-15 | 1970-04-30 | Thomae Gmbh Dr K | Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung |
BE754606A (fr) * | 1969-08-08 | 1971-02-08 | Thomae Gmbh Dr K | Nouvelles 2-aminoalcoylamino-thieno(3,2-d)pyrimidines et leurs procedesde fabrication |
BE759493A (fr) * | 1969-11-26 | 1971-05-25 | Thomae Gmbh Dr K | Nouvelles 2-(5-nitro-2-furyl)-thieno(3,2-d) pyrimidines et procedes pour les fabriquer |
US3763156A (en) * | 1970-01-28 | 1973-10-02 | Boehringer Sohn Ingelheim | 2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines |
CH592668A5 (pt) * | 1973-10-02 | 1977-10-31 | Delalande Sa | |
GB1570494A (en) * | 1975-11-28 | 1980-07-02 | Ici Ltd | Thienopyrimidine derivatives and their use as pesticides |
US4510139A (en) * | 1984-01-06 | 1985-04-09 | Sterling Drug Inc. | Substituted aminobenzamides and their use as agents which inhibit lipoxygenase activity |
EP0754684A4 (en) * | 1994-04-01 | 1998-05-13 | Shionogi & Co | OXIME DERIVATIVES AND BACTERICIDE CONTAINING IT AS ACTIVE INGREDIENTS |
US6974878B2 (en) * | 2001-03-21 | 2005-12-13 | Symyx Technologies, Inc. | Catalyst ligands, catalytic metal complexes and processes using same |
US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
US7498304B2 (en) * | 2000-06-16 | 2009-03-03 | Curis, Inc. | Angiogenesis-modulating compositions and uses |
IL153817A0 (en) * | 2000-07-19 | 2003-07-31 | Warner Lambert Co | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
US7235537B2 (en) * | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
WO2004078116A2 (en) * | 2003-03-03 | 2004-09-16 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
US20050049276A1 (en) * | 2003-07-23 | 2005-03-03 | Warner-Lambert Company, Llc | Imidazopyridines and triazolopyridines |
US7538120B2 (en) * | 2003-09-03 | 2009-05-26 | Array Biopharma Inc. | Method of treating inflammatory diseases |
US7144907B2 (en) * | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
EP1674452A4 (en) * | 2003-09-19 | 2007-10-10 | Chugai Pharmaceutical Co Ltd | NOVEL 4-PHENYLAMINO-BENZALDOXIME DERIVATIVE AND ITS USE AS MEK INHIBITOR |
US7517994B2 (en) * | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
GB0423653D0 (en) | 2004-10-25 | 2004-11-24 | Piramed Ltd | Pharmaceutical compounds |
CA2622755C (en) * | 2005-10-07 | 2017-01-31 | Exelixis, Inc. | Azetidines as mek inhibitors |
TWI409268B (zh) | 2006-04-26 | 2013-09-21 | Hoffmann La Roche | 醫藥化合物 |
JP2010500994A (ja) * | 2006-08-16 | 2010-01-14 | エグゼリクシス, インコーポレイテッド | Pi3kおよびmekモジュレーターを使用する方法 |
EP2114949A1 (en) * | 2006-12-07 | 2009-11-11 | F.Hoffmann-La Roche Ag | Phosphoinositide 3-kinase inhibitor compounds and methods of use |
PE20090678A1 (es) * | 2007-09-12 | 2009-06-27 | Genentech Inc | Combinaciones de compuestos inhibidores de fosfoinositida 3-quinasa y agentes quimioterapeuticos y los metodos de uso |
CN103841976A (zh) * | 2011-04-01 | 2014-06-04 | 基因泰克公司 | Akt和mek抑制剂化合物的组合及其使用方法 |
-
2010
- 2010-10-11 AU AU2010314287A patent/AU2010314287A1/en not_active Abandoned
- 2010-10-11 NZ NZ599939A patent/NZ599939A/en not_active IP Right Cessation
- 2010-10-11 ES ES10768448.2T patent/ES2609767T3/es active Active
- 2010-10-11 EP EP10768448.2A patent/EP2488178B1/en active Active
- 2010-10-11 MA MA34821A patent/MA33974B1/fr unknown
- 2010-10-11 JP JP2012533589A patent/JP2013507415A/ja not_active Ceased
- 2010-10-11 MX MX2012004286A patent/MX345155B/es active IP Right Grant
- 2010-10-11 PE PE2012000470A patent/PE20121816A1/es not_active Application Discontinuation
- 2010-10-11 BR BR112012008483A patent/BR112012008483A2/pt not_active IP Right Cessation
- 2010-10-11 KR KR1020127012069A patent/KR101489045B1/ko not_active IP Right Cessation
- 2010-10-11 CN CN2010800563069A patent/CN102740851B/zh not_active Expired - Fee Related
- 2010-10-11 CA CA2776944A patent/CA2776944A1/en not_active Abandoned
- 2010-10-11 WO PCT/EP2010/065149 patent/WO2011054620A1/en active Application Filing
- 2010-10-11 TW TW099134615A patent/TWI428336B/zh not_active IP Right Cessation
- 2010-10-11 RU RU2012118974/15A patent/RU2563193C2/ru not_active IP Right Cessation
- 2010-10-11 US US12/902,062 patent/US20110086837A1/en not_active Abandoned
- 2010-10-12 AR ARP100103706A patent/AR078588A1/es not_active Application Discontinuation
-
2012
- 2012-04-05 IL IL219105A patent/IL219105A0/en unknown
- 2012-04-10 CR CR20120173A patent/CR20120173A/es unknown
- 2012-04-11 ZA ZA2012/02618A patent/ZA201202618B/en unknown
- 2012-04-11 CL CL2012000913A patent/CL2012000913A1/es unknown
- 2012-04-20 CO CO12065784A patent/CO6531463A2/es not_active Application Discontinuation
- 2012-05-03 EC ECSP12011865 patent/ECSP12011865A/es unknown
-
2013
- 2013-03-04 HK HK13102634.3A patent/HK1175125A1/xx not_active IP Right Cessation
-
2014
- 2014-10-01 JP JP2014202819A patent/JP5745678B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR101489045B1 (ko) | 2015-02-02 |
EP2488178A1 (en) | 2012-08-22 |
EP2488178B1 (en) | 2016-11-16 |
ECSP12011865A (es) | 2012-06-29 |
JP2015038110A (ja) | 2015-02-26 |
KR20120064132A (ko) | 2012-06-18 |
WO2011054620A1 (en) | 2011-05-12 |
JP2013507415A (ja) | 2013-03-04 |
ZA201202618B (en) | 2014-10-29 |
NZ599939A (en) | 2014-02-28 |
US20110086837A1 (en) | 2011-04-14 |
AU2010314287A1 (en) | 2012-05-03 |
MA33974B1 (fr) | 2013-02-01 |
TW201118082A (en) | 2011-06-01 |
IL219105A0 (en) | 2012-06-28 |
ES2609767T3 (es) | 2017-04-24 |
RU2012118974A (ru) | 2013-11-20 |
PE20121816A1 (es) | 2013-01-02 |
CO6531463A2 (es) | 2012-09-28 |
CN102740851A (zh) | 2012-10-17 |
MX345155B (es) | 2017-01-18 |
TWI428336B (zh) | 2014-03-01 |
AU2010314287A2 (en) | 2012-07-12 |
AR078588A1 (es) | 2011-11-16 |
HK1175125A1 (en) | 2013-06-28 |
CR20120173A (es) | 2012-07-04 |
CL2012000913A1 (es) | 2012-09-14 |
CN102740851B (zh) | 2013-12-18 |
MX2012004286A (es) | 2012-05-22 |
RU2563193C2 (ru) | 2015-09-20 |
CA2776944A1 (en) | 2011-05-12 |
JP5745678B2 (ja) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012008483A2 (pt) | combunações de um inibidor de pi3k e um inibidor de mex | |
CY2020023I2 (el) | Αναστολεiς βητα-λακταμασων | |
DOP2012000114A (es) | Inhibidor bromodominio de benzodiazepina | |
SMT201600104B (it) | Inibitore di bromodominio benzodiazepinico | |
SMT201500271B (it) | Inibitori di neprilisina | |
DK3178818T3 (da) | Pyrazolylquinoxalinkinasehæmmere | |
DK2448938T3 (da) | Pyrimidinoner som pi3k-inhibitorer | |
DK2421825T3 (da) | Azetidinyldiamider som monoacylglycerollipase-inhibitorer | |
BRPI0918564A2 (pt) | inibidores | |
DK2453858T3 (da) | Fremgangsmåde | |
BRPI1011267A2 (pt) | inibidores de protease | |
DK2506840T3 (da) | Anvendelser af hæmmere af hypoksi-fremkaldende faktorer | |
NO20093389A (no) | Lyddemper | |
DK2516435T3 (da) | Inhibitorer af AKT-aktivitet | |
BR112013009349A2 (pt) | dispositivo de iluminação e método de fabricação de um dispositivo de iluminação | |
DK2173197T3 (da) | Fremgangsmåde | |
BR112012003059A2 (pt) | inibidores de jnk | |
SMT201500178B (it) | Inibitori di nf-kb | |
DE102009039671A8 (de) | Sanitärarmatur | |
FI20095315A0 (fi) | Iskulaite | |
IT1399897B1 (it) | Combinazione taglierina-ribobinatrice e metodo di funzionamento di una combinazione taglierina-ribobinatrice | |
FI20085971A0 (fi) | Betaiinin käyttö | |
TH105097B (th) | สารอนุพันธ์ไพร์โรโลไพริมิดีน ที่เป็นตัวยับยั้ง pi3k และการใช้ประโยชน์ของมัน | |
TH117380B (th) | สารยับยั้งไคเนสและวิธีการใช้สารเหล่านั้น | |
TH125498B (th) | สารยับยั้งไพริโดไพริมิดิโนนของ P13Ka และ mTOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |